Effects of angiotensin converting enzyme inhibitor and angiotensin II receptor antagonist therapy in hypertensive renal transplant recipients

By Kim W.   Lee S.   Kang S.K.   Yu H.C.   Cho B.H.   Park S.K.  

Transplantation Proceedings, Vol. 34, Iss. 8, 2002-12 ,pp. : 3223-3224

Elsevier

Access to resources Recommend Favorite

Aldosterone Antagonists: Evidence-Based Yet Underutilized Effective Heart Failure Therapy

By Lavie Carl J.   DiNicolantonio James J.   O'Keefe James H.   Ventura Hector O.  

Congestive Heart Failure, Vol. 19, Iss. 3, 2013-05 ,pp. : 105-106

Blackwell Publishing

Access to resources Recommend Favorite

Approach to therapy in Chronic Urticaria: When Benadryl is not enough

By Tilles Stephen A.  

Allergy and Asthma Proceedings, Vol. 26, Iss. 1, 2005-01 ,pp. : 9-12

OceanSide Publications, Inc

Access to resources Recommend Favorite

The regulation of HGF and TGF- by an angiotensin II type 1 receptor antagonist in hepatic ischemia-reperfusion injury

By Araya J.   Tsuruma T.   Hirata K.   Yagihashi A.   Meguro M.   Kawakami M.   Yanai Y.   Watanabe N.  

Transplantation Proceedings, Vol. 35, Iss. 1, 2003-02 ,pp. : 107-110

Elsevier

Access to resources Recommend Favorite

Potential Utility of Telmisartan, an Angiotensin II Type 1 Receptor Blocker with Peroxisome Proliferator-Activated Receptor-&ggr; (PPAR-&ggr;)-Modulating Activity for the Treatment of Cardiometabolic Disorders

By  

Current Molecular Medicine, Vol. 7, Iss. 5, 2007-08 ,pp. : 463-469

Bentham Science Publishers

Access to resources Recommend Favorite